期刊文献+

尼克酰胺对帕金森病模型小鼠的保护作用 被引量:1

Protective effect of nicotinamide in a mouse Parkinson′s disease model
下载PDF
导出
摘要 目的:观察尼克酰胺对1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)诱发的小鼠帕金森病(PD)模型中多巴胺能神经元的保护作用,并初步探讨其可能的作用机制。方法:在MPTP(每天30mg/kg×5 d,i.p.)注射前1h腹腔注射尼克酰胺(500 mg/kg),最后1次注射后5天观察小鼠运动能力的改变,检测纹状体多巴胺含量,并分析小鼠全脑及纹状体中乳酸脱氢酶(LDH)及一氧化氮合酶(NOS)的活性变化。结果:1)尼克酰胺能显著改善MPTP小鼠的自主运动能力(P<0.01),但对游泳、爬杆和悬挂等行为没有显著影响;2)尼克酰胺能显著减轻MPTP诱发的纹状体多巴胺含量的降低(P<0.01);3)全脑的LDH和NOS活性在各组之间没有显著差别,但纹状体的LDH和NOS活性在MPTP处理的小鼠中显著升高(P<0.01),尼克酰胺能显著降低MPTP引起的LDH和NOS活性升高(P<0.01),并且与对照组相比没有显著区别(P>0.05)。结论:尼克酰胺可以有效减轻MPTP诱发的帕金森病小鼠模型中多巴胺能神经元的损伤,这种保护作用可能与降低神经元的坏死和抑制NOS活性有关。 Objective: To examine the protective effect of nicotinamide on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced Parkinson′s disease(PD) in mouse model and its mechanisms.Methods: Parkinson′s disease was induced by injection of MPTP in adult male C57BL/6 mice,nicotinamide(500 mg/kg,i.p.) was given prior to subacute(30 mg/kg/d×5 d,i.p.) MPTP administration.Locomotor activities,striatal dopamine levels,lactate dehydrogenase(LDH) and NO synthase(NOS) activities of whole brains and striatum were analyzed at d5 after last MPTP injections.Results: Pretreatment with nicotinamide significantly improved the locomotor activity in the open-field test(P0.01),but not in the swimming test and grip climbing test.Nicotinamide administration resulted in sparing striatal dopamine levels from MPTP-induced dopamine depletion.There was no significant difference in LDH and NOS activities in the whole brains among the groups;but the activities in the striatum were drastically elevated after MPTP treatment.Nicotinamide pretreatment markedly inhibited MPTP-induced LDH and NOS activities(P0.01) and showed no significant difference compared to controls(P0.05).Conclusion: Nicotinamide protects dopaminergic neurons against MPTP-induced neurodegeneration,which suggests that the neuroprotective effects be associated with the inhibition of cell injuries and NOS activities.
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2012年第2期146-152,共7页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省教育厅资助项目(Y201017683) 国家自然科学基金资助项目(81171199)
关键词 帕金森病/药物疗法 NAD/治疗应用 一氧化氮合酶 疾病模型 动物 烟酰胺 尼克酰胺 多巴胺能神经元 乳酸脱氢酶 1-甲基-4-苯基-1 2 3 6-四氢吡啶(MPTP) Parkinson disease/drug ther NAD/ther use Nitric oxide synthase Disease models animal Niacinamide Dopaminergic neurons Lactate dehydrogenase 1-methy1-4-pheny1-1 2 3 6-tetrahydropyridine(MPTP)
  • 相关文献

参考文献23

  • 1SCHAPIRA A H,JENNER P.Etiology andpathogenesis of Parkinson's disease[J].MovDisord,2011,26(6):1049-1055.
  • 2LI F,CHONG Z Z,MAIESE K.Cell life versus celllongevity:the mysteries surrounding the NAD+precursor nicotinamide[J].Curr Med Chem,2006,13(8):883-895.
  • 3ANDERSON D W,BRADBURY K A,SCHNEIDERJ S.Broad neuroprotective profile of nicotinamide indifferent mouse models of MPTP-inducedparkinsonism[J].Eur J Neurosci,2008,28(3):610-617.
  • 4KAWAI H,MAKINO Y,HIROBE M,et al.Novelendogenous 1,2,3,4-tetrahydroisoquinolinederivatives:uptake by dopamine transporter andactivity to induce parkinsonism[J].J Neurochem,1998,70(2):745-751.
  • 5VIARO R,MARTI M,MORARI M.Dual motorresponse to l-dopa and nociceptin/orphanin FQreceptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine(MPTP)treated mice:Paradoxical inhibition is relieved by D(2)/D(3)receptor blockade[J].Exp Neurol,2010,223(2):473-484.
  • 6DONNAN G A,WILLIS G L,KACZMARCZYK S J,et al.Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse[J].JNeurosci Res,1987,77(2-3):185-191.
  • 7JIN J,MEREDITH G E,CHEN L,et al.Quantitativeproteomic analysis of mitochondrial proteins:relevance to Lewy body formation and Parkinson'sdisease[J].Brain Res Mol Brain Res,2005,134(1):119-138.
  • 8JIN J,SHIE F S,LIU J,et al.Prostaglandin E2receptor subtype 2(EP2)regulates microglialactivation and associated neurotoxicity induced byaggregated alpha-synuclein[J].J Neuroinflam-mation,2007,4:2.
  • 9PRZEDBORSKI S,VILA M.The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model:atool to explore the pathogenesis of Parkinson'sdisease[J].Ann N Y Acad Sci,2003,991:189-198.
  • 10YOKOYAMA H,KUROIWA H,KASAHARA J,etal.Neuropharmacological approach against MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropy-ridine)-induced mouse model of Parkinson's disease[J].Acta Neurobiol Exp(Wars),2011,71(2):269-280.

同被引文献9

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部